CSIMarket


Candel Therapeutics Inc   (CADL)
Other Ticker:  
 


 

Candel Therapeutics Inc

CADL's Financial Statements and Analysis



Candel Therapeutics Inc narrowed III. Quarter net loss per share of $-0.30 compare to net loss per share of $-0.69 recorded in the same quarter a year ago a decrease compare to $-0.14 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ -0.3 $  0 Mill
$+0.39     Unch.    



Candel Therapeutics Inc 's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by 0 % sequentially.


Candel Therapeutics Inc is Expected to report next financial results on March 28, 2023.

More on CADL's Income Statement



Candel Therapeutics Inc 's in III. Quarter recorded net loss of $-8.688 million, an improvement compare to net loss of $-16.162 million in III. Quarter a year ago.

Sequentially net loss advanced

More on CADL's Growth

Candel Therapeutics Inc Inventories
In III. Quarter company's net cash and cash equivalents decreased by $-10 million, capital expenditures grew by -45.15%, to $0 millions compare to same quarter a year ago and rose by -66.14% from II. Quarter (Jun 30 2022).

More on CADL's Cash flow Statement


Candel Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Candel Therapeutics Inc payed $ -1.03 cash per share, on a free-cash flow basis .

Book value fell by -13.47 % sequentially to $1.80 per share.
Tangible Book value fell to $ 1.80 per share from $ 2.09.

Company issued 0.08 million shares or 0.28 % in III. Quarter.
Debt Coverage Ratio was 1.25.

More on CADL's Dividends

 Market Capitalization (Millions) 43
 Shares Outstanding (Millions) 29
 Total Debt (Millions $) 21
 Revenue (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 20
 Cash Flow (TTM) (Millions $) -11
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Candel Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Candel Therapeutics Inc had negative $ -1.03 cash flow per share, on a free-cash flow basis .

Book value fell by -13.47 % sequentially to $1.80 per share.
Tangible Book value fell to $ 1.80 per share from $ 2.09.

Company issued 0.08 million shares or 0.28 % in III. Quarter.
Debt Coverage Ratio was 1.25.

More on CADL's Balance Sheets

 Market Capitalization (Millions) 43
 Shares Outstanding (Millions) 29
 Total Debt (Millions $) 21
 Revenue (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 20
 Cash Flow (TTM) (Millions $) -11
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GCO's Profile

Stock Price

GCO's Financials

Business Description

Fundamentals

Charts & Quotes

GCO's News

Suppliers

GCO's Competitors

Customers & Markets

Economic Indicators

GCO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071